GREM1 and cancer: GREM1, which was also significantly upregulated by HE4 stable overexpression or rHE4 treatment, is overexpressed in a wide variety of cancers, including uterine cervical, lung, ovary, kidney, breast, colon, pancreas, and sarcoma (39), and has been shown to promote metastatic properties.